Technical Analysis for LIXT - Lixte Biotech Hldgs

Grade Last Price % Change Price Change
grade D 0.95 0.00% 0.0000
LIXT closed unchanged on Thursday, December 5, 2019, on 1.17 times normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
See historical LIXT trend table...

Date Alert Name Type % Chg
1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
200 DMA Resistance Bearish 0.00%
1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Older signals for LIXT ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Lixte Biotechnology Holdings, Inc., including its subsidiary, Lixte Biotechnology, Inc., is a drug discovery company that uses biomarker technology to identify enzyme targets associated with serious common diseases and then designs compounds to attack those targets. The Company's primary focus is developing new treatments for human cancers. The Company designs drugs for which there are existing data suggesting that they may affect the altered pathways of the cancer cell and may be given safely to humans. This approach has led to the development of over two classes of drugs for the treatment of cancer, consisting of protein phosphatase inhibitors (PTase-i), designated by the Company as the LB-100 series of compounds, and histone deacetylase inhibitors (HDACi), designated by the Company as the LB-200 series of compounds. Compounds of both types also have use in the prevention and treatment of neurodegenerative diseases.
Branches Of Biology Cancer Health Sciences Treatment Of Cancer Drug Discovery Pharmaceutical Sciences Antineoplastic Drugs Neurodegenerative Diseases Histone Deacetylase

Is LIXT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 1.84
52 Week Low 0.22
Average Volume 3,407
200-Day Moving Average 0.9876
50-Day Moving Average 1.1349
20-Day Moving Average 1.0565
10-Day Moving Average 0.9604
Average True Range 0.0930
ADX 35.3
+DI 18.7668
-DI 40.2937
Chandelier Exit (Long, 3 ATRs ) 1.0110
Chandelier Exit (Short, 3 ATRs ) 1.0690
Upper Bollinger Band 1.2857
Lower Bollinger Band 0.8273
Percent B (%b) 0.27
BandWidth 43.3885
MACD Line -0.0648
MACD Signal Line -0.0513
MACD Histogram -0.0135
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.9500
Resistance 3 (R3) 0.9500 0.9500 0.9500
Resistance 2 (R2) 0.9500 0.9500 0.9500 0.9500
Resistance 1 (R1) 0.9500 0.9500 0.9500 0.9500 0.9500
Pivot Point 0.9500 0.9500 0.9500 0.9500 0.9500
Support 1 (S1) 0.9500 0.9500 0.9500 0.9500 0.9500
Support 2 (S2) 0.9500 0.9500 0.9500 0.9500
Support 3 (S3) 0.9500 0.9500 0.9500
Support 4 (S4) 0.9500